Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target

K Schimmel, K Ichimura, S Reddy, F Haddad… - Frontiers in …, 2022 - frontiersin.org
Myocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …

Right ventricular fibrosis: a pathophysiological factor in pulmonary hypertension?

S Andersen, JE Nielsen-Kudsk, A Vonk Noordegraaf… - Circulation, 2019 - Am Heart Assoc
The role of right ventricular (RV) fibrosis in pulmonary hypertension (PH) remains a subject
of ongoing discussion. Alterations of the collagen network of the extracellular matrix may …

Right ventricular adaptation and failure in pulmonary arterial hypertension

JJ Ryan, J Huston, S Kutty, ND Hatton… - Canadian Journal of …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is an obstructive pulmonary vasculopathy,
characterized by excess proliferation, apoptosis resistance, inflammation, fibrosis, and …

Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in …

L Tian, D Wu, A Dasgupta, KH Chen… - Circulation …, 2020 - Am Heart Assoc
Rationale: Right ventricular (RV) fibrosis in pulmonary arterial hypertension contributes to
RV failure. While RV fibrosis reflects changes in the function of resident RV fibroblasts …

Decorin regulates the aggrecan network integrity and biomechanical functions of cartilage extracellular matrix

B Han, Q Li, C Wang, P Patel, SM Adams, B Doyran… - ACS …, 2019 - ACS Publications
Joint biomechanical functions rely on the integrity of cartilage extracellular matrix.
Understanding the molecular activities that govern cartilage matrix assembly is critical for …

Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension

SZ Prisco, T Thenappan, KW Prins - Basic to Translational Science, 2020 - jacc.org
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …

TGF-β and BMPR2 signaling in PAH: two black sheep in one family

N Rol, KB Kurakula, C Happé, HJ Bogaard… - International journal of …, 2018 - mdpi.com
Knowledge pertaining to the involvement of transforming growth factor β (TGF-β) and bone
morphogenetic protein (BMP) signaling in pulmonary arterial hypertension (PAH) is …

Fibroblasts and the extracellular matrix in right ventricular disease

NG Frangogiannis - Cardiovascular research, 2017 - academic.oup.com
Right ventricular failure predicts adverse outcome in patients with pulmonary hypertension
(PH), and in subjects with left ventricular heart failure and is associated with interstitial …

Hypertensive heart disease: a narrative review series—part 1: pathophysiology and microstructural changes

V Nemtsova, AS Vischer, T Burkard - Journal of clinical medicine, 2023 - mdpi.com
Sustained hypertension causes structural, functional, and neurohumoral abnormalities in the
heart, a disease commonly termed hypertensive heart disease (HHD). Modern concepts of …

Emerging concepts in the molecular basis of pulmonary arterial hypertension: part II: neurohormonal signaling contributes to the pulmonary vascular and right …

BA Maron, JA Leopold - Circulation, 2015 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is defined foremost by a distinct pulmonary vascular
pathophenotype that occurs as a result of dysregulated vascular cell proliferation, intimal …